OMALIZUMAB
omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device
OMALIZUMAB (14950W)
14950W
Manner of administration:Injection
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $104.54 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||